Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Next-Generation Cervical Disc Treats Degenerative Disease

By HospiMedica International staff writers
Posted on 14 Feb 2016
A new artificial disc system is designed to provide a long term, flexible alternative for cervical disk replacement procedures.

The Rhine cervical disc system features a one-piece compressible elastomeric polymer core with dome-shaped, plasma-coated endplates and a central-split keel that are intended to minimize wear and tear between the polymer core and metal endplates. More...
Fabricated using a proprietary molding technology, the monolithic compressible polymer core design was shown to be comparable to the natural cervical disc when subjected to biomechanical testing.

The system also feature a streamlined instrumentation kit that simplifies the surgical technique by integrating both disc trialing and keel cutting into a single instrument, and also includes a built-in adjustable stop that allows for customized anterior or posterior positioning of the disc, based on surgeon preference. The Rhine cervical disc system is a product of K2M (Leesburg, VA, USA), and has received the European Community CE marking of approval.

“We are excited to receive a CE mark for our Rhine cervical disc technology, as it represents an important regulatory milestone event for K2M as we continue to build our product portfolio and penetrate the global spine market with innovative techniques and technologies,” said Eric Major, President and CEO of K2M. “We look forward to further expanding our international product offering, and will remain focused on the complex spine category across all of our international markets.”

“The Rhine cervical disc system is manufactured through a proprietary over-molding process of elastomeric polymer that differentiates the system from the competitive offering,” said principal inventor of the Rhine, orthopedic surgeon Casey Lee, MD. “The first single and multi-level surgical procedures using the Rhine system were recently completed in Belgium and Germany. We are committed to showing successful clinical results and are initiating a prospective observational clinical study in multiple sites throughout Europe.”

Related Links:

K2M



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Radiation Safety Barrier
RayShield Intensi-Barrier
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.